OSE Immunotherapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Institutions | 279,479 | 1.3% |
Private Companies | 788,700 | 3.66% |
Individual Insiders | 5,413,960 | 25.1% |
General Public | 15,086,963 | 69.9% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 16.7%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
2,007,163 | €11.3m | 0% | no data | |||
1,860,049 | €10.5m | 0% | no data | |||
929,862 | €5.2m | 0% | no data | |||
788,700 | €4.4m | 0% | no data | |||
424,084 | €2.4m | 0% | no data | |||
192,802 | €1.1m | 0% | no data | |||
126,996 | €716.3k | 0% | 0.07% | |||
110,000 | €620.4k | 0% | 0.26% | |||
30,483 | €171.9k | 0% | 0.03% | |||
12,000 | €67.7k | 0% | 1.5% |